| API | active pharmaceutical ingredient |
| ATCC | American type culture collection |
| ATMP | advanced therapy medicinal product |
| bp | base pairs |
| CAM | chorioallantoic membrane |
| CHUV | Centre hospitalier universitaire Vaudois |
| DMEM | Dulbecco’s modified Eagle medium |
| DMSO | dimethyl sulfoxide |
| DNA | deoxyribonucleic acid |
| EDQM | European Directorate for the Quality of Medicines & Healthcare |
| EOPCB | end of production cell bank |
| EP | European Pharmacopoeia |
| EU | European Union |
| FBS | fetal bovine serum |
| FDA | US Food and Drug Administration |
| FPC | fibroblast progenitor cell |
| GMP | good manufacturing practices |
| HIV | human immunodeficiency virus |
| hPL | human platelet lysate |
| ICH | International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use |
| iPSC | induced pluripotent stem cells |
| MCB | master cell bank |
| MRC | Medical Research Council |
| MSC | mesenchymal stem cells |
| NA | not applicable |
| NIBSC | National Institute for Biological Standards and Control |
| NIH | National Institutes of Health |
| PBB | Progenitor Biological Bandage |
| PCB | parental cell bank |
| PDL | population doubling level |
| PL | passage level |
| SV40 | simian virus 40 |
| US | United States of America |
| WCB | working cell bank |
| WHO | World Health Organization |
| WI | Wistar Institute |